. HCMV seroprevalenceThere have been over published studies which present HCMV IgG seroprevalence data for sub-Saharan Africa patient groups and cohorts of healthy blood donors Table . Up to eight different serology assays were used and older pre-ELISA methods might have slightly underestimated prevalence [ ]. Antibodies to HCMV are generally present in high titres in seropositive individuals, so the use of different assays is unlikely to have had a major effect [ ]. Hence, comparing these studies is primarily confounded by the diverse range of patient groups tested. Few studies stratify by age, or they do so using different groupings. Most of the studies use convenience samples, which do not provide accurate population-based estimates of prevalence.The most striking observation is that HCMV primary infection appears to be endemic in young infants. A population-based study in Zambia of healthy infants showed % HCMV seroprevalence by months of age [ ] Table . This backs up much older studies from the Gambia [ ] and Nigeria [ ]. This differs from the results of larger studies in the USA n = , where HCMV seroprevalence ranges from % in -year-olds to % in those over years old. The cumulative incidence of HCMV primary infection was ~ % per year from adolescence [ ]. In the USA, non-white ethnicity and lower socioeconomic status SES were linked with -percentage point increases in seroprevalence [ ]. A study of over , women in the U.K attending antenatal clinics found similar results, with increasing parity also being linked with increased HCMV seroprevalence. This supports the notion that seronegative adult women contract primary HCMV infection from children who are shedding virus [ ]. Figure presents a model for cumulative HCMV seroprevalence by age with respect to SES, showing more rapid uptake in low SES communities, and delayed uptake in high SES communities. Conversely an Israeli study found the effect of ethnicity persisted even when corrected for gender, education and SES [ ], and high HCMV seroprevalence has been described in populations with high SES groups [ , ].